What is the Future of Immunosuppression Management in Cancer Therapy?
The future of managing immunosuppression in cancer therapy looks promising with ongoing research and advancements. The development of biomarkers to predict which patients are at higher risk of immunosuppression can lead to more tailored treatment approaches. Innovations in gene therapy and the use of CAR-T cells are also opening new avenues to boost immune function in a targeted manner. Continuous efforts to understand the complex interactions between cancer and the immune system will likely yield more effective strategies to manage immunosuppression.
